2023 Partners
CosmosID
Innovation Partner:
CosmosID® is a global leader in supporting the pharmaceutical sector with CLIA-certified, ICH-GCP compliant microbiome and microbial isolate solutions for applications such as pre-clinical, clinical, CMC and regulatory support. In addition to Next Generation Sequencing workflows, CosmosID also offers validated, industry-leading bioinformatics, yielding multi-kingdom, strain-level resolution with leading sensitivity and precision. CosmosID-HUB, a user-friendly and interactive software for comparative analysis of microbiome data, complete with dynamic charts, visualizations, and statistics is used by researchers around the world for enabling downstream analysis & interpretation.
Precion
Exhibition Partner:
Precion applies mass spectrometry technology to provide targeted metabolite panels for profiling various chronic disease conditions and associated health areas for clinical research. Precion offers diagnostics and precision medicine assay formats for downstream applications. Our testing services for commercial and research customers provides data for various sample types and project objectives. We offer a range of targeted panels as well as custom developed panels for areas including microbiome testing of serum/plasma/stool samples.
Biose Industrie
Exhibition Partner:
Biose Industrie is a Contract Development and Manufacturing Organization (CDMO), specialised in Live Biotherapeutic Products. Founded in 1951 by pharmacists and microbiologists, Biose Industrie has been manufacturing drug substance and drug products based on microorganisms for 60 years. Company, with 10 000m² of GMP facilty, offers product development at laboratory and pilot scale specialised in microbiology for aerobie and anaerobie strains and is Drug GMP certified for the manufacturing of API, clinical batches and commercial products.
![Secondary logo RGB[95]](https://microbiome-infant-health.com/wp-content/uploads/sites/24/2022/05/Secondary-logo-RGB95.png "Secondary logo RGB[95]"){kind=logo}
Clinical Microbiomics
Event Partner:
Clinical Microbiomics offers GCLP-compliant end-to-end pipelines in metagenomics and metabolomics. To understand maturation of the infant microbiome and its interaction with HMOs, the immune system, early life events and the mother’s microbiome, we offer a comprehensive infant-microbiome framework and extensive expertise in early-life microbiome development: 1) industry leading microbiome profiling that enables tracking of maternal strains with unprecedented precision and sensitivity; 2) systems biological setup with hand curated annotation of microbial HMO metabolizing capabilities; 3) Machine learning models for the infant microbiome maturation; 4) microbiome community type models for trajectory analysis; 5) immunological expertise; 6) metabolome panels for infant microbiome.